Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jiangsu Hengrui Medicine Co., Ltd.
  6. News
  7. Summary
    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Market Chatter: Jiangsu Hengrui Medicine to Invest $20 Million in Drug Research Company Under Oncology Deal

02/10/2021 | 12:47am EDT


© MT Newswires 2021
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
07/01MARKET CHATTER : China Adds New Drugs to Cover Under Health Insurance Program
MT
06/24China stocks slip as healthcare firms retreat; Hong Kong up
RE
05/21Jiangsu Hengrui Pharmaceuticals Co., Ltd. Announces on Obtaining Notice of Ap..
CI
05/03Shanghai Fosun Pharmaceutical's H-Shares Surge to All-Time High
DJ
04/19Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Qua..
CI
03/15EXCLUSIVE : China's JD.com in talks to buy stake worth $1.5 billion in brokerage..
RE
03/11Jiangsu Hengrui Medicine Co., Ltd. Announces Approval of Conducting Clinical ..
CI
02/10MARKET CHATTER : Jiangsu Hengrui Medicine to Invest $20 Million in Drug Research..
MT
02/08Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Exp..
CI
2020Drugmakers agree to halve prices to get on China state insurance list
RE
More news
Financials
Sales 2021 34 368 M 5 303 M 5 303 M
Net income 2021 7 631 M 1 177 M 1 177 M
Net cash 2021 19 829 M 3 060 M 3 060 M
P/E ratio 2021 50,6x
Yield 2021 0,33%
Capitalization 392 B 60 436 M 60 441 M
EV / Sales 2021 10,8x
EV / Sales 2022 8,98x
Nbr of Employees 28 903
Free-Float 46,5%
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 61,49 CNY
Average target price 86,46 CNY
Spread / Average Target 40,6%
EPS Revisions
Managers and Directors
Yun Shu Zhou Chairman & General Manager
Song Zhou Chief Financial Officer
Wei Dong Chairman-Supervisory Board
Shuang Xue Independent Director
Qian Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
JOHNSON & JOHNSON8.01%432 430
ROCHE HOLDING AG11.02%325 975
PFIZER, INC.12.66%218 198
ELI LILLY AND COMPANY41.25%209 276
NOVARTIS AG0.20%207 246